Literature DB >> 17684087

Pelvic-floor strength in women with incontinence as assessed by the brink scale.

Mary P FitzGerald1, Kathryn L Burgio, Diane F Borello-France, Shawn A Menefee, Joseph Schaffer, Stephen Kraus, Veronica T Mallett, Yan Xu.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to describe how clinical pelvic-floor muscle (PFM) strength (force-generating capacity) is related to patient characteristics, lower urinary tract symptoms, and fecal incontinence symptoms.
SUBJECTS: Data were obtained from 643 women who were participating in a randomized surgical trial for treatment of stress urinary incontinence.
METHODS: Patient demographic variables, baseline urinary and fecal incontinence symptom questionnaires, urodynamic data and urinary diary data, pad test results, and standardized assessment of pelvic organ support were compared with PFM strength as described by the Brink scoring system. Bivariate analysis of factors associated with the Brink scale score was done using analysis of variance and linear regression. Multivariate analysis included patient variables that were significant on bivariate analysis.
RESULTS: The mean Brink scale score was 9 (SD=2) and did not vary widely in this large, but highly select, patient sample. We found a weak, but statistically strong, relationship between age and Brink score. Brink scores were not related to diary and pad test measures of incontinence severity. DISCUSSION AND
CONCLUSION: Overall, PFM strength was good in this sample of women with stress incontinence. Scores tended to be similar, and it is possible that the Brink scale does not reflect real clinical differences in PFM strength.

Entities:  

Mesh:

Year:  2007        PMID: 17684087     DOI: 10.2522/ptj.20060073

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  7 in total

1.  Comparing Vitamin D Supplementation Versus Placebo for Urgency Urinary Incontinence: A Pilot Study.

Authors:  Alayne D Markland; Vin Tangpricha; T Mark Beasley; Camille P Vaughan; Holly E Richter; Kathryn L Burgio; Patricia S Goode
Journal:  J Am Geriatr Soc       Date:  2018-12-21       Impact factor: 5.562

2.  Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial.

Authors:  Matthew D Barber; Linda Brubaker; Kathryn L Burgio; Holly E Richter; Ingrid Nygaard; Alison C Weidner; Shawn A Menefee; Emily S Lukacz; Peggy Norton; Joseph Schaffer; John N Nguyen; Diane Borello-France; Patricia S Goode; Sharon Jakus-Waldman; Cathie Spino; Lauren Klein Warren; Marie G Gantz; Susan F Meikle
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

3.  Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial.

Authors:  J Eric Jelovsek; Matthew D Barber; Linda Brubaker; Peggy Norton; Marie Gantz; Holly E Richter; Alison Weidner; Shawn Menefee; Joseph Schaffer; Norma Pugh; Susan Meikle
Journal:  JAMA       Date:  2018-04-17       Impact factor: 56.272

Review 4.  Open retropubic colposuspension for urinary incontinence in women.

Authors:  Marie Carmela M Lapitan; June D Cody; Atefeh Mashayekhi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 5.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Haroon Rehman; Carlos A Bezerra; Homero Bruschini; June D Cody; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

6.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Lucky Saraswat; Haroon Rehman; Muhammad Imran Omar; June D Cody; Patricia Aluko; Cathryn Ma Glazener
Journal:  Cochrane Database Syst Rev       Date:  2020-01-28

7.  Reliability of pelvic floor muscle strength assessment in healthy continent women.

Authors:  Dulcegleika V B Sartori; Monica O Gameiro; Hamilto A Yamamoto; Paulo R Kawano; Rodrigo Guerra; Carlos R Padovani; João L Amaro
Journal:  BMC Urol       Date:  2015-04-10       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.